Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07QMR
|
||||
| Former ID |
DNC013293
|
||||
| Drug Name |
N-(1-(4-phenylbutyl)piperidin-4-yl)-1-naphthamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528639] | ||
| Formula |
C26H30N2O
|
||||
| Canonical SMILES |
C1CN(CCC1NC(=O)C2=CC=CC3=CC=CC=C32)CCCCC4=CC=CC=C4
|
||||
| InChI |
1S/C26H30N2O/c29-26(25-15-8-13-22-12-4-5-14-24(22)25)27-23-16-19-28(20-17-23)18-7-6-11-21-9-2-1-3-10-21/h1-5,8-10,12-15,23H,6-7,11,16-20H2,(H,27,29)
|
||||
| InChIKey |
JATDEOORDLHCRO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [528639] | |
| PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.